杭州奥泰生物技术股份有限公司2025年第三季度报告

Core Viewpoint - The company, Hangzhou Aotai Biological Technology Co., Ltd., has announced significant changes to its governance structure, including the cancellation of the supervisory board and amendments to its articles of association to enhance operational efficiency and compliance with legal regulations [8][9]. Financial Data - The third-quarter financial statements for 2025 have not been audited, indicating that the financial data presented may not have undergone external verification [3][7]. - The company reported that there were no significant changes in the financial indicators or accounting data during the reporting period [5]. Governance Changes - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors, which aligns with the requirements of the Company Law of the People's Republic of China [8]. - The company plans to appoint one independent director and one employee representative director to improve the composition of the board [8]. Compliance and Legal Responsibility - The board of directors and senior management have guaranteed the authenticity, accuracy, and completeness of the quarterly report, assuming legal responsibility for any misrepresentation or omissions [2][8].